HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,650,000
- Total 13F shares
- 127,472,754
- Share change
- +281,086
- Total reported value
- $2,260,145,336
- Put/Call ratio
- 40%
- Price per share
- $17.73
- Number of holders
- 218
- Value change
- +$7,244,846
- Number of buys
- 114
- Number of sells
- 93
Quarterly Holders Quick Answers
What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40637H109:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
12%
|
14,228,129
|
$220,678,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
11%
|
13,004,538
|
$201,701,000 | — | 30 Sep 2019 | |
| Third Security, LLC |
13F
|
Company |
7.8%
|
9,706,087
|
$150,541,000 | — | 30 Sep 2019 | |
| Bellevue Group AG |
13F
|
Company |
6.5%
|
8,014,356
|
$124,303,000 | — | 30 Sep 2019 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
4.4%
|
5,415,995
|
$84,002,000 | — | 30 Sep 2019 | |
| Invesco Ltd. |
13F
|
Company |
4.3%
|
5,266,794
|
$81,688,000 | — | 30 Sep 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.1%
|
5,024,697
|
$77,933,000 | — | 30 Sep 2019 | |
| STATE STREET CORP |
13F
|
Company |
3.6%
|
4,510,918
|
$69,964,000 | — | 30 Sep 2019 | |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
|
Company |
3.6%
|
4,462,433
|
$69,212,000 | — | 30 Sep 2019 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
3.1%
|
3,865,719
|
$59,957,000 | — | 30 Sep 2019 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
2.6%
|
3,160,743
|
$49,023,000 | — | 30 Sep 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
2.4%
|
3,017,306
|
$46,798,000 | — | 30 Sep 2019 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
2.2%
|
2,721,858
|
$42,216,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
2.1%
|
2,561,426
|
$39,728,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.6%
|
2,005,625
|
$31,108,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,824,500
|
$28,297,000 | — | 30 Sep 2019 | |
| NORGES BANK |
13F
|
Company |
1.5%
|
1,810,203
|
$28,076,000 | — | 30 Sep 2019 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.4%
|
1,682,745
|
$26,099,000 | — | 30 Sep 2019 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
1.3%
|
1,637,475
|
$25,397,000 | — | 30 Sep 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,603,701
|
$24,873,000 | — | 30 Sep 2019 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
1.2%
|
1,540,616
|
$23,894,000 | — | 30 Sep 2019 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1%
|
1,292,163
|
$20,041,000 | — | 30 Sep 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1%
|
1,265,341
|
$19,625,000 | — | 30 Sep 2019 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
1%
|
1,244,666
|
$19,305,000 | — | 30 Sep 2019 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.95%
|
1,169,916
|
$18,145,000 | — | 30 Sep 2019 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.85%
|
1,052,974
|
$16,332,000 | — | 30 Sep 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.83%
|
1,029,443
|
$15,967,000 | — | 30 Sep 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.79%
|
972,470
|
$15,083,000 | — | 30 Sep 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
904,946
|
$14,036,000 | — | 30 Sep 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.72%
|
888,938
|
$13,787,429 | — | 30 Sep 2019 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.7%
|
867,396
|
$13,453,000 | — | 30 Sep 2019 | |
| Elk Creek Partners, LLC |
13F
|
Company |
0.61%
|
758,553
|
$11,765,000 | — | 30 Sep 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.61%
|
750,000
|
$11,633,000 | — | 30 Sep 2019 | |
| Man Group plc |
13F
|
Company |
0.59%
|
727,733
|
$11,287,000 | — | 30 Sep 2019 | |
| S.c.a. Candriam |
13F
|
Individual |
0.52%
|
647,079
|
$10,036,000 | — | 30 Sep 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.52%
|
643,467
|
$9,981,000 | — | 30 Sep 2019 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.51%
|
636,167
|
$9,867,000 | — | 30 Sep 2019 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.45%
|
558,391
|
$8,661,000 | — | 30 Sep 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.44%
|
548,665
|
$8,510,000 | — | 30 Sep 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.43%
|
532,517
|
$8,260,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.43%
|
528,091
|
$8,191,000 | — | 30 Sep 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.4%
|
489,002
|
$7,584,000 | — | 30 Sep 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
406,062
|
$6,299,000 | — | 30 Sep 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.3%
|
375,083
|
$5,818,000 | — | 30 Sep 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.3%
|
373,064
|
$5,785,000 | — | 30 Sep 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.28%
|
349,820
|
$5,426,000 | — | 30 Sep 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.27%
|
338,060
|
$5,243,000 | — | 30 Sep 2019 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.26%
|
320,373
|
$4,969,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
315,161
|
$4,888,000 | — | 30 Sep 2019 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.24%
|
300,000
|
$4,653,000 | — | 30 Sep 2019 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q4 2019
As of 31 Dec 2019,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
218 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,472,754 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, Third Security, LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Artisan Partners Limited Partnership, Invesco Ltd., JPMORGAN CHASE & CO, STATE STREET CORP, and SNYDER CAPITAL MANAGEMENT L P.
This page lists
218
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
206
Q4 2019 holders
218
Holder diff
12
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.